Article Text

PDF
P77 Hypoxic challenge testing for fitness to fly in severe asthma
  1. CM Orton,
  2. PM George,
  3. S Ward,
  4. A Menzies-Gow,
  5. JH Hull
  1. The Royal Brompton, London, UK

Abstract

Introduction and objectives Commercial airline travel poses a recognised risk to patients with respiratory disease, including in those with asthma. Hypoxic challenge testing (HCT) is typically employed to mitigate this risk by dictating in-flight oxygen requirement. The objective of this work was to evaluate the role of HCT in patients with severe asthma.

Methods A retrospective analysis was performed of all BTS/SIGN Asthma Step 5 adult individuals under the Royal Brompton Hospital severe asthma service, who completed HCT between 2007 and 2014. In line with British Thoracic Society recommendations, under hypoxic conditions a reduction in PaO2 to <6.6 kPa was reported as a positive result. A PaO2 level of 6.6–7.5 kPa was considered borderline and supplemental oxygen was advised if co-existent evidence of hyperventilation. Electrocardiograph monitoring was performed in all patients during the HCT.

Results Of the 37 patients studied, 21 (57%) had a positive HCT. Individuals with a positive HCT had a lower PaO2 under normoxic conditions (10.1 kPa v 11.4 kPa, p < 0.01), but similar PaCO2 level (4.80 kPa v 4.91 kPa, p > 0.05). Baseline oxygen saturation was poorly predictive of the need for supplementary oxygen and two-thirds of patients, for whom supplementary oxygen was recommended, had a baseline SpO2 level of greater than 95%; approximately half of these individuals de-saturated to less that 90% on HCT (Figure 1). Lung function was more obstructed in the positive HCT group (predicted FEV1 (52% v 78%, p < 0.01). Across the entire cohort, HCT was associated with a mean rise in heart rate (HR) of 5 bpm and there was no evidence of dysrhythmia or change in QTc. A combination of any two of: baseline PaO2 ≤ 10.5 kPa, FEV1 ≤ 60% predicted and PEF ≤ 350 L/min predicted the need for in-flight oxygen with a sensitivity of 90% and a specificity of 69%.

Conclusions In patients with severe asthma, baseline oxygen saturation level is poorly predictive of the need for in-flight oxygen. Our findings indicate that a HTC should be considered for all BTS/SIGN Step 5 asthmatics in whom air travel is being considered and should certainly be recommended in those with impaired lung function.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.